Biogen Reports Third Quarter 2026 Results
Revenue$2.8 billion+11% YoY
Adj. EPS$2.62
Outlookloweredguidance
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.